Tuesday, July 30, 2019 3:51:36 PM
Yep. We all know that Cannabis works for a lot of ailments.
There are a bunch of Individual Reports and Articles on how it helps MS, Epilepsy, Insomnia, Chronic Pain, and the list goes on and on.
BUT WHEN is the FDA or Harvard Medical School going to step-up and do a complete and comprehensive study?
I really think the Medical Community and the Drug Manufacturers are AFRAID of Cannabis.
They are AFRAID it is going to upset the apple-cart and their business.
I mean, why go to an MD if you have Insomnia when you can just go to your local dispensary instead?
I really think that the MD's and Pharmacies are afraid that Cannabis is going to steal their business. That is why the FDA will not study Cannabis as a "main stream" medicine.
However, for anyone who has used Cannabis for Chronic Pain - everyone will tell you it works - WITHOUT any side effects (like Death from OPIODS).
There are a bunch of Individual Reports and Articles on how it helps MS, Epilepsy, Insomnia, Chronic Pain, and the list goes on and on.
BUT WHEN is the FDA or Harvard Medical School going to step-up and do a complete and comprehensive study?
I really think the Medical Community and the Drug Manufacturers are AFRAID of Cannabis.
They are AFRAID it is going to upset the apple-cart and their business.
I mean, why go to an MD if you have Insomnia when you can just go to your local dispensary instead?
I really think that the MD's and Pharmacies are afraid that Cannabis is going to steal their business. That is why the FDA will not study Cannabis as a "main stream" medicine.
However, for anyone who has used Cannabis for Chronic Pain - everyone will tell you it works - WITHOUT any side effects (like Death from OPIODS).
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/21/2026 09:05:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 12:44:17 PM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (US) • 05/14/2026 10:54:00 AM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (Canada) • 05/14/2026 10:54:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
